DK0549621T3 - Hidtil ukendte leukotrien-B4-antagonister, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel - Google Patents
Hidtil ukendte leukotrien-B4-antagonister, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddelInfo
- Publication number
- DK0549621T3 DK0549621T3 DK91915659.6T DK91915659T DK0549621T3 DK 0549621 T3 DK0549621 T3 DK 0549621T3 DK 91915659 T DK91915659 T DK 91915659T DK 0549621 T3 DK0549621 T3 DK 0549621T3
- Authority
- DK
- Denmark
- Prior art keywords
- radical
- group
- antagonists
- alkyl
- drug
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/94—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4028866A DE4028866A1 (de) | 1990-09-07 | 1990-09-07 | Neue leukotrien-b(pfeil abwaerts)4(pfeil abwaerts)-antagonisten, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0549621T3 true DK0549621T3 (da) | 1996-01-08 |
Family
ID=6414066
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK91915659.6T DK0549621T3 (da) | 1990-09-07 | 1991-08-28 | Hidtil ukendte leukotrien-B4-antagonister, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel |
Country Status (13)
Country | Link |
---|---|
US (1) | US5352701A (da) |
EP (1) | EP0549621B1 (da) |
JP (1) | JPH06504984A (da) |
AT (1) | ATE128453T1 (da) |
AU (1) | AU8403791A (da) |
CA (1) | CA2091182A1 (da) |
DE (2) | DE4028866A1 (da) |
DK (1) | DK0549621T3 (da) |
ES (1) | ES2078541T3 (da) |
GR (1) | GR3018261T3 (da) |
HU (1) | HUT63372A (da) |
NO (1) | NO930747D0 (da) |
WO (1) | WO1992004311A1 (da) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5451700A (en) * | 1991-06-11 | 1995-09-19 | Ciba-Geigy Corporation | Amidino compounds, their manufacture and methods of treatment |
US5488160A (en) * | 1991-06-11 | 1996-01-30 | Ciba-Geigy Corporation | Amidino compounds, their manufacture and method of treatment |
DE4127193A1 (de) * | 1991-08-15 | 1993-02-18 | Schering Ag | Neue leukotrien-b(pfeil abwaerts)4(pfeil abwaerts)-antagonisten, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
EP0641569A4 (en) * | 1992-03-12 | 1997-01-29 | Ono Pharmaceutical Co | ANTIPRURIGINOUS AGENT. |
DE4224402A1 (de) * | 1992-07-21 | 1994-01-27 | Schering Ag | Neue Pyridin-Derivate mit Leukotrien-B¶4¶-antagonistischer Wirkung |
US6669929B1 (en) | 2002-12-30 | 2003-12-30 | Colgate Palmolive Company | Dentifrice containing functional film flakes |
US8093253B2 (en) * | 2008-03-06 | 2012-01-10 | Hoffmann-La Roche Inc. | Leukotriene B4 inhibitors |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4661505A (en) * | 1982-11-03 | 1987-04-28 | Eli Lilly And Company | Leukotriene antagonists |
US4567184A (en) * | 1982-12-01 | 1986-01-28 | Usv Pharmaceutical Corporation | Certain aryl or hetero-aryl derivatives of 1-hydroxy-pentane or 1-hydroxy-hexane which are useful for treating inflammation and allergies |
CA1242195A (en) * | 1983-07-18 | 1988-09-20 | David K. Herron | Leukotriene antagonists |
US5105017A (en) * | 1983-07-18 | 1992-04-14 | Eli Lilly And Company | Leukotriene antagonist intermediates |
SE8400239D0 (sv) * | 1984-01-19 | 1984-01-19 | Pharmacia Ab | Nya arylettiksyraderivat |
US4992576A (en) * | 1987-01-12 | 1991-02-12 | Eli Lilly And Company | Intermediates for leukotriene antagonists |
CA1320490C (en) * | 1987-01-12 | 1993-07-20 | Darrel M. Gapinski | Anti-inflammatory agents |
-
1990
- 1990-09-07 DE DE4028866A patent/DE4028866A1/de not_active Withdrawn
-
1991
- 1991-08-28 WO PCT/DE1991/000690 patent/WO1992004311A1/de active IP Right Grant
- 1991-08-28 AT AT91915659T patent/ATE128453T1/de not_active IP Right Cessation
- 1991-08-28 DE DE59106603T patent/DE59106603D1/de not_active Expired - Fee Related
- 1991-08-28 HU HU93623A patent/HUT63372A/hu unknown
- 1991-08-28 CA CA002091182A patent/CA2091182A1/en not_active Abandoned
- 1991-08-28 JP JP3513850A patent/JPH06504984A/ja active Pending
- 1991-08-28 AU AU84037/91A patent/AU8403791A/en not_active Abandoned
- 1991-08-28 DK DK91915659.6T patent/DK0549621T3/da active
- 1991-08-28 EP EP91915659A patent/EP0549621B1/de not_active Expired - Lifetime
- 1991-08-28 ES ES91915659T patent/ES2078541T3/es not_active Expired - Lifetime
-
1993
- 1993-03-01 NO NO930747A patent/NO930747D0/no unknown
- 1993-05-05 US US08/050,195 patent/US5352701A/en not_active Expired - Fee Related
-
1995
- 1995-11-30 GR GR950403375T patent/GR3018261T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE4028866A1 (de) | 1992-03-12 |
NO930747L (no) | 1993-03-01 |
CA2091182A1 (en) | 1992-03-08 |
AU8403791A (en) | 1992-03-30 |
US5352701A (en) | 1994-10-04 |
NO930747D0 (no) | 1993-03-01 |
ES2078541T3 (es) | 1995-12-16 |
ATE128453T1 (de) | 1995-10-15 |
JPH06504984A (ja) | 1994-06-09 |
HUT63372A (en) | 1993-08-30 |
WO1992004311A1 (de) | 1992-03-19 |
EP0549621B1 (de) | 1995-09-27 |
DE59106603D1 (de) | 1995-11-02 |
GR3018261T3 (en) | 1996-02-29 |
EP0549621A1 (de) | 1993-07-07 |
HU9300623D0 (en) | 1993-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL318878A1 (en) | Novel drug precursors, method of obtaining them, pharmaceutic agent and method of making same, application of such precursors in production of said pharmaceutic agent and pharmaceutic preparation | |
MY103233A (en) | Novel thiazole derivatives active on the cholinergic system, process for obtention and pharmaceutical compositions | |
AU2201088A (en) | 1-((2-pyrimidinyl)aminoalkyl)piperidines, their preparation and their application in therapy | |
NO20015172L (no) | 1-metyl-erytromycin-derivater | |
AU631743B2 (en) | New chalcones, process for preparing these and pharmaceutical compositions containing them | |
DK0549621T3 (da) | Hidtil ukendte leukotrien-B4-antagonister, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel | |
AU4950593A (en) | 2, 6-dihydroxy phenyl propanionic acid derivatives, process for their production and their use as pharmaceutical agents | |
TW366343B (en) | Piperidine derivatives and anti-platelet agents containing the same | |
YU182581A (en) | Process for preparing new 5,10-dihydro-11h-dibenzo-(b,e)(1,4)diazepine-11-ones substituted in position 5 | |
DE68903680T2 (de) | 6-phenyl-3-piperazinylalkyl-1h,3h-pyrimidindion-2,4-derivate, deren herstellung und verwendung als heilmittel. | |
HUT57183A (en) | Process for producing hydrazone derivatives and pharmaceutical preparatives containing said compounds | |
HU9202260D0 (en) | 9-halogene-11beta-hydroxi-prostaglandine derivatives method for producing them and their utilization as medicament | |
ES8702379A1 (es) | Un procedimiento para la produccion de 1h-tetrazol-5-carboxamidas-n-sustituidas. | |
AU2845489A (en) | Process for preparing hydroxyakylating agents, the agents so obtained, and their use | |
NO940448L (no) | Nye leukotrien-B4-antagonister, fremgangsmåte for fremstilling av slike samt deres anvendelse som farmasöytiske midler | |
ES8704897A1 (es) | Procedimiento para la obtencion de 1,4-dihidropiridinas | |
ES8203876A1 (es) | Procedimiento de obtencion de nuevos a-amino derivados ci- clicos del 1-(3',4'-metilendioxifenil)etanol | |
ES8704915A1 (es) | Procedimiento para la obtencion de dihidrotiazinas asimetri-cas | |
IL71430A0 (en) | Iminosulfonamides and process for their production,pharmaceutical compositions containing such compounds and the use thereof | |
GR3021761T3 (en) | Leukotriene-b 4? derivatives, process for preparing the same and medicaments. | |
AU1234588A (en) | New acetamides derived from 2,3-dihydro-3-phenyl-2-benzofuranone, processes for preparing them and the pharmaceutical compositions which contain them | |
DE3169296D1 (en) | Cephalosporin derivatives and their preparation | |
MX9707911A (es) | Derivados de amina 1-[w-(3,4-dihidro-2-naftalenil)alquil]- ciclica, proceso para su preparacion y composiciones farmaceuticas que contienen los mismos. |